drugset
drugset / Trial / NCT03802682

A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Participants

NCT03802682 ↗

Phase 1 Completed 12 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to determine the bioavailability of apalutamide tablets administered orally as dispersed tablets mixed in applesauce relative to whole tablets under fasting conditions in healthy male participants.

Timeline

Start
2019-01-11
Primary completion
2019-04-11
Completion
2019-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Apalutamide Small molecule 240 mg Oral

Indications

No indication recorded.